Cardiac output, heart rate, and blood pressure as influenced by equi-antiarrhythmic doses of eight antifibrillatory agents.
D031841:Aconitum / Q000008:administration & dosage; D000404:Ajmaline / Q000008:administration & dosage; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001794:Blood Pressure / Q000187:drug effects*; D001919:Bradycardia / Q000139:chemically induced; D002200:Capillary Resistance / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects*; D002306:Cardiac Volume / Q000187:drug effects; D004987:Ethers / Q000008:administration & dosage; D005021:Ethylamines / Q000008:administration & dosage; D005990:Glycerol / Q000008:administration & dosage; D006339:Heart Rate / Q000187:drug effects*; D008012:Lidocaine / Q000008:administration & dosage; D008297:Male; D010672:Phenytoin / Q000008:administration & dosage; D011342:Procainamide / Q000008:administration & dosage; D011433:Propranolol / Q000008:administration & dosage; D011802:Quinidine / Q000008:administration & dosage; D051381:Rats; D012121:Respiration, Artificial; D013034:Sparteine / Q000008:administration & dosage
D000889:Anti-Arrhythmia Agents; D004987:Ethers; D005021:Ethylamines; D000404:Ajmaline; D013034:Sparteine; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide; D005990:Glycerol